{
    "Trade/Device Name(s)": [
        "Dimension EXL High-Sensitivity Troponin I (TNIH) Assay"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics, Inc.",
    "510(k) Number": "K190675",
    "Predicate Device Reference 510(k) Number(s)": [
        "K162895"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MMI"
    ],
    "Summary Letter Date": "March 18, 2019",
    "Summary Letter Received Date": "March 19, 2019",
    "Submission Date": "March 14, 2019",
    "Regulation Number(s)": [
        "21CFR862.1215"
    ],
    "Regulation Name(s)": [
        "Creatine phosphokinase/creatine kinase or isoenzymes test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cardiac troponin I"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Dimension EXL integrated chemistry system with LOCI module"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous sandwich chemiluminescent immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Dimension EXL High-Sensitivity Troponin I (TNIH) Assay measuring cardiac troponin I using chemiluminescent immunoassay on Dimension EXL system",
    "Indications for Use Summary": "For in vitro diagnostic quantitative measurement of cardiac troponin I in human plasma to aid in the diagnosis of acute myocardial infarction (AMI)",
    "fda_folder": "Clinical Chemistry"
}